Merck Sharp and Dohme AB (MSD Sweden)

Sweden

1 December 2019 - 30 November 2020

No articles found. Merck Sharp and Dohme AB (MSD Sweden) did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Merck & Co., Inc.

↳ Merck Sharp and Dohme AB (MSD Sweden)

Intervet International B.V.

MRL Netherlands

MRL Singapore

MRL South Korea

MSD Animal Health

MSD Animal Health - UK

MSD Animal Health Cologne

MSD Animal Health Norge

MSD R&D (China) Co., Ltd.

MSD Translational Medicine Research Centre (TMRC), Merck Sharp & Dohme Corp.

Merck - Rahway

Merck Canada Inc.

Merck Research Laboratories (MRL)

Merck Research Laboratories Rome

IRBM Science Park SpA

Merck Sharp and Dohme B.V. (MSD BV Haarlem)

Merck Sharp and Dohme Limited (MSD UK)

Merck Sharp and Dohme de España S.A. (MSD Spain)

OncoEthix GmbH

Schering-Plough Laboratory for Immunological Research

Merck Sharp and Dohme AG (MSD Switzerland)

Return to institution outputs

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free

Research highlights of partners

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up

Useful links